American Airlines may split up big jet order

DALLAS (AP) — American Airlines plans to announce a major order of new planes Wednesday that is likely to include aircraft from longtime supplier, Boeing Co., and from Europe’s Airbus, a person familiar with the matter said.

The move to acquire more fuel-efficient planes could put pressure on other airlines to upgrade their fleets.

American, whose fleet of more than 600 planes averages about 15 years in age, is weighing competing bids from Boeing and Airbus.

The final order will likely include planes from both aircraft makers, according the person familiar with the matter, who spoke on condition of anonymity because an official announcement had not been made. T

Find more info…

July 18, 2011 No Comments »
Posted by Xavier Kopsen
Tags: American Airlines, Order

USAA, other insurers may lose top ratings on threat to Treasurys

San Antonio’s USAA and other large insurers may lose their top credit ratings as officials debate raising the federal debt ceiling, Standard & Poor’s said.

Besides USAA, New York Life Insurance Co., Northwestern Mutual Life Insurance Co., Teachers Insurance & Annuity Association of America and Knights of Columbus may lose their AAA credit ratings, S&P said Friday in a statement.

The insurers have “significant holdings” of U.S. Treasury and agency securities, according to the statement.

“S&P’s action is solely related to the condition of the U.S. government,” USAA spokesman Paul Berry said in an email. “This has no impact on USAA’s business model, financial performance or ability to make good on its commitment to members.”

S&P said in its statement that the insurers are “constrained by the U.S. sovereign credit rating because their businesses and assets are highly concentrated in the U.S.”

“This means USAA’s ratings cannot be higher than the U.S. rating,” Berry said.

On Thursday, S&P said the U.S. government’s long-t

Find more info…

July 16, 2011 No Comments »
Posted by Xavier Kopsen
Tags: Insurers May, Insurers May Lose, May Lose, Ratings

Google Up 13% on Great Earnings and Google +: Is Facebook in Trouble?

On June 24, Berkshire Hathaway acquired the 1.4 million shares (19.9 percent) of Wesco Financial it didn’t already own for $385 per share. Wesco’s CEO was 87-year-old Charlie Munger, who is also vice-chairman of Berkshire. Munger is getting on in years and probably didn’t want the workload associated with being a CEO, so Warren Buffett helped out his old friend by absorbing the company.

In his final meeting with Wesco shareholders on July 1, Munger was asked whether he thinks current technology leaders Google (NasdaqGS: GOOG), Intel (NasdaqGS: INTC), and Apple (NasdaqGS: AAPL) face competitive threats. Munger’s answer was enlightening:

I don’t know how you displace Google, but a lot of the other companies will have competitive troubles.

That’s right, folks, forget about Apple and Intel — only Google has the sustainable competitive advantage that Munger and Buffett look for in a long-term investment. This was not the first time that Munger had spoken positively about Google. Back in May

Find more info…

July 16, 2011 No Comments »
Posted by Xavier Kopsen

Snoop Dogg Wants to Write “Baby Making Music” for Prince William and Kate Middleton

The famous rapper has professed his love for the Royal Couple with an offer to write the song that can start their own family.

The controversial and always amusing hip hop legend Snoop Dogg is a fan of the Royal couple, even saying how much he loves the Brits. “Kate and Wills, oh wow, what a couple. They need to make some babies soon to give the Queen some great grandkids. They’re going to be beautiful babies” says the rapper to the tabloid The Sun.

  • Instead of letting Prince William and Kate make their way into forming a family, the rapper reveals his plans to help the couple do exactly just that “Perhaps I’ll record them their own baby-making music” says the rapper to the same interview.

    Find more info…

    July 16, 2011 No Comments »
    Posted by Xavier Kopsen
    Tags: Snoop Dogg, Write

    Market Report: GSK slides on fears over prospects for lung drug

    With the blue-chip index enduring its second major sell-off in a row, GlaxoSmithKline was left deep in the red as questions were raised over the chances of its major new lung drug gaining approval.

    The pharmaceutical giant slipped back 25.5p to 1,281.5p after revealing the results of clinical studies on Relovair, which it hopes will replace its best selling product Advair. Although the majority of the targets were met, in one test GSK admitted that the drug did not show a “consistent statistical significance” when compared to one of its components on its own.

    “It raises the regulatory risks,” said Deutsche Bank’s Mark Clark, who warned that regulatory bodies will need to be convinced that the combination found in Relovair produces a significant difference.

    With longer-term studies still to be completed before approval is applied for, GSK described the results as “an important milestone”, although Theravance – the US group which is a partner in the product – also saw its share price slump on the Nasdaq.

    Overall, the FTSE 100 shed 80.69 points to finish at 5,847.92, meaning it has been knocked back over 140 points in the last two days, as the recent run of poor global economic data raised fears ahead of today’s closely watched non-farm payroll figures from the US.

    Speculation that Barclays could be looking to Spain for a potential acquisition knocked the bank back 3.95p to 265.7p after Evolution Securities said the prospect of it buying one of the country’s savings banks, known as “cajas”, was looking “increasingly likely”. “We

    Find more info…

    July 16, 2011 No Comments »
    Posted by Xavier Kopsen
    Tags: Drug, Lung Drug